Objectives. The aim of this study was to examine the incidence and characte
ristics of women who develop a second molar pregnancy after a previous epis
ode of gestational trophoblastic disease.
Methods. A retrospective analysis was carried out on completed registration
forms from referring hospitals in the North of England to the Sheffield Tr
ophoblastic Screening Service over a 13-year period. Ail cases of second mo
lar pregnancy were identified. Details of histology, blood group, ethnic or
igin, age, and subsequent pregnancies were examined.
Results. Between 1 January 1985 and 31 December 1997, 5030 patients were re
gistered for follow-up and 275 (5.5%) required treatment for persistent dis
ease. Thirty-five women had a subsequent molar pregnancy, a total of 0.70%
of all registrations. There was no significant difference in age at first r
egistration between those who were registered for one molar event and those
who developed a subsequent molar pregnancy. The risk of a second molar eve
nt was highest in the second year after the initial diagnosis and reduced t
hereafter. There was a trend toward an increased risk of second molar pregn
ancy in Indian/Pakistani women when compared to Caucasian women (relative r
isk 2.4) but this was not significant at conventional levels. There was a s
ignificantly increased incidence of blood group B in patients that develope
d a molar pregnancy when compared to the normal population (P < 0.05), but
there was no difference in distribution of blood group between those regist
ered for their first molar event and those with two or more events. Patient
s who presented with a partial mole tended to have a partial mole as the se
cond event but patients who presented with a complete mole were at risk of
a subsequent complete mole, partial mole, or choriocarcinoma. Six percent o
f patients required chemotherapy for the second molar event, indicating no
increase in aggressiveness in second moles. Two patients had three molar ev
ents.
Conclusion. In the United Kingdom the risk of second molar pregnancy is les
s than 1%. There is an increased risk of molar pregnancy in women with bloo
d group B and a trend toward an increased risk of second molar pregnancy in
Indian/Pakistani women. Only 6%\ of patients required chemotherapy for the
second mole; a second molar pregnancy is not an indication for chemotherap
y. (C) 2000 Academic Press.